Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

November 29, 2018

Study Completion Date

November 29, 2018

Conditions
ObesityObesity, MorbidObesity; EndocrineBariatric Surgery Candidate
Interventions
PROCEDURE

Gastric mucosal devitalization

During routine laparoscopic sleeve gastrectomy surgery, once the greater curvature of the stomach is excised as per normal surgical technique, the investigators will take the specimen out and perform an ablation ex-vivo, with the intention of performing selective mucosal devitalization. This specimen will then be transported to pathology lab for analysis.

Trial Locations (1)

21202

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

Erbe USA Incorporated

OTHER

lead

Johns Hopkins University

OTHER

NCT03526263 - Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy | Biotech Hunter | Biotech Hunter